본문 바로가기
KERD
논문KCI 등재

Preventive Effects of Low Parathyroid Hormone Levels on Hip Fracture in Patients with Vitamin D Deficiency

0

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류정형외과학

초록

Background: The objective of the current study is to determine the role of serum parathyroid hormone (PTH) on hip fracture development by retrospectively analyzing the relationship between vitamin D and PTH levels and hip fracture prevalence. Methods: Among 288 patients over 50 years of age, 113 patients with hip fracture and 111 controls without fracture were analyzed after excluding patients with conditions affecting bone metabolism. Bone mineral density and serum biochemical markers were measured, while demographic data were obtained. Patients were divided into 4 groups according to serum 25-hydroxy-vitamin D (25-[OH]D) and PTH levels: LowD+LowP (low 25[OH]D and PTH); LowD+HighP, (low 25[OH]D and high PTH); HighD+LowP (high 25[OH]D and low PTH); and HighD+HighP, patients with (high 25[OH]D and PTH). Measured values and percentages of patients with hip fracture in each group were then determined and compared. Results: The number of patients included in the LowD+LowP, LowD+HighP, HighD+LowP, and HighD+HighP groups was 116, 17, 87, and 4, while the percentages of patients with hip fracture in the same groups were 60.3%, 88.2%, 27.6%, and 100%, respectively. The percentage of hip fracture was significantly lower in the LowD+LowP than the LowD+HighP group (P=0.049). Conclusions: Patients with low serum 25(OH)D and PTH levels showed lower hip fracture prevalence, indicating the potential protective role of low PTH levels on bone health in patients with vitamin D deficiency. Therefore, clinicians should pay more attention to the possibility of fractures in patients with vitamin D deficiency who present with high PTH levels.

Abstract

Background: The objective of the current study is to determine the role of serum parathyroid hormone (PTH) on hip fracture development by retrospectively analyzing the relationship between vitamin D and PTH levels and hip fracture prevalence. Methods: Among 288 patients over 50 years of age, 113 patients with hip fracture and 111 controls without fracture were analyzed after excluding patients with conditions affecting bone metabolism. Bone mineral density and serum biochemical markers were measured, while demographic data were obtained. Patients were divided into 4 groups according to serum 25-hydroxy-vitamin D (25-[OH]D) and PTH levels: LowD+LowP (low 25[OH]D and PTH); LowD+HighP, (low 25[OH]D and high PTH); HighD+LowP (high 25[OH]D and low PTH); and HighD+HighP, patients with (high 25[OH]D and PTH). Measured values and percentages of patients with hip fracture in each group were then determined and compared. Results: The number of patients included in the LowD+LowP, LowD+HighP, HighD+LowP, and HighD+HighP groups was 116, 17, 87, and 4, while the percentages of patients with hip fracture in the same groups were 60.3%, 88.2%, 27.6%, and 100%, respectively. The percentage of hip fracture was significantly lower in the LowD+LowP than the LowD+HighP group (P=0.049). Conclusions: Patients with low serum 25(OH)D and PTH levels showed lower hip fracture prevalence, indicating the potential protective role of low PTH levels on bone health in patients with vitamin D deficiency. Therefore, clinicians should pay more attention to the possibility of fractures in patients with vitamin D deficiency who present with high PTH levels.

참고문헌 (36)

  1. Lips P, "Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications", Endocr Rev, 22, pp.477~501 (2001)
  2. Kuchuk NO, "Relationships of serum 25-hydroxyvitamin D to bone mineral density and serum parathyroid hormone and markers of bone turnover in older persons", J Clin Endocrinol Metab, 94, pp.1244~1250 (2009)
  3. Rejnmark L, "Parathyroid response to vitamin D insufficiency: relations to bone, body composition and to lifestyle characteristics", Clin Endocrinol (Oxf), 69, pp.29~35 (2008)
  4. Sahota O, "The relationship between vitamin D and parathyroid hormone: calcium homeostasis, bone turnover, and bone mineral density in postmenopausal women with established osteoporosis", Bone, 35, pp.312~319 (2004)
  5. Chapuy MC, "Healthy elderly French women living at home have secondary hyperparathyroidism and high bone turnover in winter. EPIDOS Study Group", J Clin Endocrinol Metab, 81, pp.1129~1133 (1996)
  6. Bakhtiyarova S, "Vitamin D status among patients with hip fracture and elderly control subjects in Yekaterinburg, Russia", Osteoporos Int, 17, pp.441~446 (2006)
  7. Holick MF, "Vitamin D deficiency", N Engl J Med, 357, pp.266~281 (2007)
  8. Bi X, "Prevalence of vitamin D deficiency in Singapore: Its implications to cardiovascular risk factors", PLoS One, 11, pp.e0147616~ (2016)
  9. 정인경, "한국인의 비타민 D 부족 유병률에 관한 연구:국민건강영양조사 2010~2011 분석결과", Journal of Nutrition and Health, 46(6), pp.540~551 (2013), 한국영양학회[DOI]
  10. 최의성, "한국에서의 고관절 골절 빈도는 여전히 증가 추세인가?: 건강보험 데이터베이스를 이용한 역학연구", 대한정형외과학회지, 51(6), pp.447~454 (2016), 대한정형외과학회
  11. Suda T, "Vitamin D and bone", J Cell Biochem, 88, pp.259~266 (2003)
  12. Teitelbaum SL, "Bone resorption by osteoclasts", Science, 289, pp.1504~1508 (2000)
  13. Bischoff-Ferrari HA, "Dietary calcium and serum 25-hydroxyvitamin D status in relation to BMD among U.S. adults", J Bone Miner Res, 24, pp.935~942 (2009)
  14. Hannan MT, "Serum 25-hydroxyvitamin D and bone mineral density in a racially and ethnically diverse group of men", J Clin Endocrinol Metab, 93, pp.40~46 (2008)
  15. Kuchuk NO, "Vitamin D status, parathyroid function, bone turnover, and BMD in postmenopausal women with osteoporosis: global perspective", J Bone Miner Res, 24, pp.693~701 (2009)
  16. Hagström E, "Positive effect of parathyroidectomy on bone mineral density in mild asymptomatic primary hyperparathyroidism", J Intern Med, 259, pp.191~198 (2006)
  17. Jorde R, "Bone mineral density and blood pressure in patients with asymptomatic hyperparathyroidism", The Tromso Study. J Intern Med, 247, pp.325~330 (2000)
  18. Cummings SR, "Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group", N Engl J Med, 332, pp.767~773 (1995)
  19. Dhanwal DK, "Hip fracture patients in India have vitamin D deficiency and secondary hyperparathyroidism", Osteoporos Int, 24, pp.553~557 (2013)
  20. Larrosa M, "Hypovitaminosis D as a risk factor of hip fracture severity", Osteoporos Int, 23, pp.607~614 (2012)
  21. Sakuma M, "Vitamin D and intact PTH status in patients with hip fracture", Osteoporos Int, 17, pp.1608~1614 (2006)
  22. Sahota O, "Hypovitaminosis D and 'functional hypoparathyroidism'-the NoNoF (Nottingham Neck of Femur) study", Age Ageing, 30, pp.467~472 (2001)
  23. Melhus H, "Plasma 25-hydroxyvitamin D levels and fracture risk in a community-based cohort of elderly men in Sweden", J Clin Endocrinol Metab, 95, pp.2637~2645 (2010)
  24. Yamauchi M, "Role of parathyroid hormone in bone fragility of postmenopausal women with vitamin D insufficiency", Calcif Tissue Int, 88, pp.362~369 (2011)
  25. Amouzougan A, "Functional hypoparathyroidism in postmenopausal women with fragility fracture", Joint Bone Spine, 79, pp.170~175 (2012)
  26. 김현목, "The Association of Higher Plasma Macrophage Migration Inhibitory Factor Levels with Lower Bone Mineral Density and Higher Bone Turnover Rate in Postmenopausal Women", Endocrinology and Metabolism, 31(3), pp.454~461 (2016), 대한내분비학회
  27. Lips P, "A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial", J Clin Endocrinol Metab, 86, pp.1212~1221 (2001)
  28. Mosekilde L, "Primary hyperparathyroidism and the skeleton", Clin Endocrinol (Oxf), 69, pp.1~19 (2008)
  29. Rejnmark L, "Increased fracture risk in normocalcemic postmenopausal women with high parathyroid hormone levels: a 16-year follow-up study", Calcif Tissue Int, 88, pp.238~245 (2011)
  30. Sikjaer T, "Effects of PTH(1-84) therapy on muscle function and quality of life in hypoparathyroidism: results from a randomized controlled trial", Osteoporos Int, 25, pp.1717~1726 (2014)
  31. Gielen E, "Endocrine determinants of incident sarcopenia in middle-aged and elderly European men", J Cachexia Sarcopenia Muscle, 6, pp.242~252 (2015)
  32. Renoud A, "Predictive parameters of accelerated muscle loss in men-MINOS study", Am J Med, 127, pp.554~561 (2014)
  33. Serhan E, "Prevalence of hypovitaminosis D in Indo-Asian patients attending a rheumatology clinic", Bone, 25, pp.609~611 (1999)
  34. Holick MF, "High prevalence of vitamin D inadequacy and implications for health", Mayo Clin Proc, 81, pp.353~373 (2006)
  35. Malabanan A, "Redefining vitamin D insufficiency", Lancet, 351, pp.805~806 (1998)
  36. Thomas MK, "Hypovitaminosis D in medical inpatients", N Engl J Med, 338, pp.777~783 (1998)

관련 논문AI추천

이 간행물의 다른 논문 (7건)